i really feel nader and team really worked hard on getting partnerships/license agreements so i will not fault them. had they received an fda approval even for tnbc there would be no crisis situation now. the fda absurdity to reject our tnbc
on the grounds the mos is only 2-3 months improved over trodelvy is a little over the top. leronlimab side effect factor certainly destroys trodelvy . what can i say
maybe we should merge with bp and call it a day ?